These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12102721)

  • 1. Aib-based peptide backbone as scaffolds for helical peptide mimics.
    Banerjee R; Basu G; Chène P; Roy S
    J Pept Res; 2002 Aug; 60(2):88-94. PubMed ID: 12102721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of introducing aib in a designed helical inhibitor of hdm2-p53 interaction: A molecular dynamics study.
    Chattopadhyay S; Ajani H; Basu G
    Biopolymers; 2016 Jan; 106(1):51-61. PubMed ID: 26537425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational preferences of a short Aib/Ala-based water-soluble peptide as a function of temperature.
    Banerjee R; Chattopadhyay S; Basu G
    Proteins; 2009 Jul; 76(1):184-200. PubMed ID: 19137603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of Putative Helix-Breaking Amino Acids in the Design of Novel Stapled Peptides: Exploring Biophysical and Cellular Permeability Properties.
    Partridge AW; Kaan HYK; Juang YC; Sadruddin A; Lim S; Brown CJ; Ng S; Thean D; Ferrer F; Johannes C; Yuen TY; Kannan S; Aronica P; Tan YS; Pradhan MR; Verma CS; Hochman J; Chen S; Wan H; Ha S; Sherborne B; Lane DP; Sawyer TK
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31226791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a retroinverso p53 peptide as an inhibitor of MDM2.
    Sakurai K; Chung HS; Kahne D
    J Am Chem Soc; 2004 Dec; 126(50):16288-9. PubMed ID: 15600307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helical beta-peptide inhibitors of the p53-hDM2 interaction.
    Kritzer JA; Lear JD; Hodsdon ME; Schepartz A
    J Am Chem Soc; 2004 Aug; 126(31):9468-9. PubMed ID: 15291512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
    J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C
    Banerjee R; Sheet T; Banerjee S; Biondi B; Formaggio F; Toniolo C; Peggion C
    Biochemistry; 2021 Sep; 60(36):2704-2714. PubMed ID: 34463474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced protein thermostability by Ala-->Aib replacement.
    De Filippis V; De Antoni F; Frigo M; Polverino de Laureto P; Fontana A
    Biochemistry; 1998 Feb; 37(6):1686-96. PubMed ID: 9484240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a beta-hairpin to mimic an alpha-helix: cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction.
    Fasan R; Dias RL; Moehle K; Zerbe O; Vrijbloed JW; Obrecht D; Robinson JA
    Angew Chem Int Ed Engl; 2004 Apr; 43(16):2109-12. PubMed ID: 15083458
    [No Abstract]   [Full Text] [Related]  

  • 11. NMR solution structure of a peptide from the mdm-2 binding domain of the p53 protein that is selectively cytotoxic to cancer cells.
    Rosal R; Pincus MR; Brandt-Rauf PW; Fine RL; Michl J; Wang H
    Biochemistry; 2004 Feb; 43(7):1854-61. PubMed ID: 14967026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational manifold of alpha-aminoisobutyric acid (Aib) containing alanine-based tripeptides in aqueous solution explored by vibrational spectroscopy, electronic circular dichroism spectroscopy, and molecular dynamics simulations.
    Schweitzer-Stenner R; Gonzales W; Bourne GT; Feng JA; Marshall GR
    J Am Chem Soc; 2007 Oct; 129(43):13095-109. PubMed ID: 17918837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of a beta-peptide ligand for hDM2.
    Kritzer JA; Hodsdon ME; Schepartz A
    J Am Chem Soc; 2005 Mar; 127(12):4118-9. PubMed ID: 15783163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site.
    Do TN; Rosal RV; Drew L; Raffo AJ; Michl J; Pincus MR; Friedman FK; Petrylak DP; Cassai N; Szmulewicz J; Sidhu G; Fine RL; Brandt-Rauf PW
    Oncogene; 2003 Mar; 22(10):1431-44. PubMed ID: 12629507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein.
    DiGiammarino EL; Filippov I; Weber JD; Bothner B; Kriwacki RW
    Biochemistry; 2001 Feb; 40(8):2379-86. PubMed ID: 11327858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of p53-derived ligands to MDM2 induces a variety of long range conformational changes.
    Schon O; Friedler A; Freund S; Fersht AR
    J Mol Biol; 2004 Feb; 336(1):197-202. PubMed ID: 14741215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length.
    Lai Z; Auger KR; Manubay CM; Copeland RA
    Arch Biochem Biophys; 2000 Sep; 381(2):278-84. PubMed ID: 11032416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
    Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
    Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deracemization and the first CD spectrum of a 3(10)-helical peptide made of achiral α-amino-isobutyric acid residues in a chiral membrane mimetic environment.
    Ceccacci F; Mancini G; Rossi P; Scrimin P; Sorrenti A; Tecilla P
    Chem Commun (Camb); 2013 Oct; 49(86):10133-5. PubMed ID: 24049772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoinhibition of MDMX by intramolecular p53 mimicry.
    Chen L; Borcherds W; Wu S; Becker A; Schonbrunn E; Daughdrill GW; Chen J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4624-9. PubMed ID: 25825738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.